Christian Heubeck
Dipl.-Chem., Dr. rer. nat., Patent Attorney, European Patent Attorney, European Trademark and Design Attorney
German Patent Attorney since 2008
European Patent Attorney since 2008
European Trademark and Design Attorney since 2008
Partner since 2011
Richard-Strauss-Straße 80
81679 München
+49 (0)89 - 45563 0
email@weickmann.de
Fields of Activity
- Preparation of patent applications and patent grant proceedings before the European Patent Office, particularly in the field of biochemistry, physiological chemistry, immunology, pharmaceuticals, medical engineering and fuel cells, advanced materials
- Defending property rights and attacking third-party rights before the European Patent Office and the German Patent and Trademark Office (opposition and nullity proceedings)
- Freedom-to-operate analyses
- Licensing agreements
- Preparation of and advice on IP strategies and patent portfolios
- Employee Inventions Act
Awards
- IAM Patent 1000 - since 2020 individually recommended
- Leader`s League - since 2021 individually recommended
- The Legal 500 - since 2023 individually recommended
Education
- Studied Chemistry at the Julius Maximilian University in Würzburg and at University College Galway, Ireland (diploma 1998)
- Worked as research assistant at the Institute for Biochemistry of the Julius Maximilian University in Würzburg and the University of Leipzig for several years, focusing on research into ribonucleases, and teaching the subject
- Doctoral thesis on composition of eukaryotic ribonuclease P in plants and plastids (Dr. rer. nat. 2003)
- Has been working in intellectual property since 2004
Memberships and other activities
- German Chamber of Patent Attorneys (Patentanwaltskammer)
- epi (European Patent Institute)
- GDCh ("Gesellschaft Deutscher Chemiker" – Association of German Chemists)
- Honorary expert at the Science4Life start-up initiative
Languages
- German
- English
Publications
- Repeated publications on current and subject-specific topics on intellectual property rights, e.g.
- „IP for Business Plans and Investor Meetings” (2021)
- “Patent Protection vs. Public Interest, Patenting AI in Life Sciences” (2021)
- “Clinical trials and personalised medicines – life science patentability issues in Europe 2020”
- “Eligiblity issues, Antibodies, CRISPR -life science patentability issues in Europe 2019”
- "Patenting stem cells and genes in Europe" (2017)
- "Patenting personalised medicines in Europe" (2018)
- Licensing after the pandemic" (2022)